(Q38224784)

31 August 2017

Diagnosis and treatment of chronic acquired demyelinating polyneuropathies (English)

1 reference

31 August 2017

Norman Latov

1

1 reference

PubMed ID

24980070

31 August 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

31 August 2017

Nature Reviews Neurology

1 reference

31 August 2017

10

1 reference

31 August 2017

8

1 reference

31 August 2017

435-446

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2014.117

31 August 2017

0 references

cites work

Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Epidemiology of chronic inflammatory neuropathies in southeast England

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Charcot-Marie-Tooth disease: genetic and clinical spectrum in a Spanish clinical series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Nerve conduction studies in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Current diagnosis of CIDP: the need for biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Sensory action potentials and biopsy of the sural nerve in neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Sensory pathophysiology in chronic acquired demyelinating neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP)--diagnosis confirmed by nerve biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Sensory CIDP presenting as cryptogenic sensory polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory demyelinating polyneuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

The spectrum of chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory lumbosacral polyradiculopathy: a regional variant of CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Focal neuropathy preceding chronic inflammatory demyelinating polyradiculoneuropathy by several years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Early neurophysiological evolution of chronic inflammatory demyelinating polyneuropathy in a patient with Hashimoto's thyroiditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Nerve size in chronic inflammatory demyelinating neuropathy varies with disease activity and therapy response over time: a retrospective ultrasound study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Characterization of neuropathies associated with elevated IgM serum levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Drug-induced neuropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Conduction block in vasculitic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Biomarkers of CIDP in patients with diabetes or CMT1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic relapsing polyneuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Plasma-Cell Dyscrasia and Peripheral Neuropathy with a Monoclonal Antibody to Peripheral-Nerve Myelin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Physiological tremor analysis of patients with anti-myelin-associated glycoprotein associated neuropathy and tremor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Neuropathy with predominant small fiber involvement associated with abnormal anti-MAG titer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

IgM monoclonal gammopathy and neuropathy in two siblings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Three families with polyneuropathy associated with monoclonal gammopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Coexistence of Charcot-Marie-Tooth disease type 1A and anti-MAG neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Coexistence of hereditary motor and sensory neuropathy type Ia and IgM paraproteinemic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

An Autopsy Case of Amyotrophic Lateral Sclerosis with Waldenström Macroglobulinemia and Anti-MAG Gammopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Autopsy-proven amyotrophic lateral sclerosis, Waldenström's macroglobulinemia, and antibodies to sulfated glucuronic acid paragloboside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Neuropathy and anti-MAG antibodies without detectable serum M-protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Anti-myelin-associated glycoprotein antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Anti-MAG and anti-SGPG antibodies in neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Les polyneuropathies avec IgM monoclonale anti-MAG : étude descriptive clinique, biologique, électrophysiologique et anatomopathologique d’une cohorte de 13 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immunofixation superior to plasma agarose electrophoresis in detecting small M-components in patients with polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy caused by a B‐cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immunofluorescence study of patients with neuropathy and IgM M proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immune reactive C3d on the surface of myelin sheaths in neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Morphological changes in IgM paraproteinaemic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Myelin modifications in 8 cases of peripheral neuropathy with Waldenström's macroglobulinemia and anti-MAG activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immunoglobulin deposits in peripheral nerve endings detected by skin biopsy in patients with IgM M proteins and neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Electrophysiologic study of experimental demyelination induced by serum of patients with IgM M proteins and neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Macroglobulinemia with peripheral neuropathy simulating motor neuron disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Motor Neuropathy with Proximal Multifocal Persistent Conduction Block, Fasciculations and Myokymia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy presenting as ophthalmoplegia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy with and without conduction block: A single entity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Axonal multifocal motor neuropathy without conduction block or other features of demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy without overt conduction block

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic motor axonal neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Motor nerve biopsy studies in motor neuropathy and motor neuron disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Diagnostic biopsy of the pronator teres and a motor branch of the median nerve: indications and technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Diagnostic biopsy of the motor nerve to the gracilis muscle. Technical note

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

The sensitivity and specificity of anti-GM1 antibody testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal demyelinating motor neuropathy: pathologic evidence of 'inflammatory demyelinating polyradiculoneuropathy'

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Gammopathy with proximal motor axonopathy simulating motor neuron disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic motor axonal neuropathy: pathological evidence of inflammatory polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Pathological findings at the site of conduction block in multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy: pathologic alterations at the site of conduction block

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Motor nerve biopsy: Clinical usefulness and histopathological criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Sensory nerve pathology in multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

The Crow-Fukase syndrome: a study of 102 cases in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

18F-FDG PET/CT in the evaluation of POEMS syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

An autopsied case of the Crow-Fukase syndrome: a neuropathological study with emphasis on spinal roots

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, The Netherlands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Long-term effects of intravenous immunoglobulin in CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Long-term complications of past glucocorticoid use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Pathogenesis and Treatment of Anti-MAG Neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Fludarabine may overcome resistance to rituximab in IgM-related neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Anti-MAG IgM antibodies in patients with neuropathy and IgM M proteins: detection by ELISA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Polyneuropathies associated with IgM monoclonal gammopathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

[Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Intravenous immunoglobulin for multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Immunosuppressive treatment in multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Deterioration of multifocal motor neuropathy after plasma exchange

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

[Efficacy of autologous peripheral blood stem cell transplantation (auto-PBSCT) on the neuropathic manifestations in POEMS syndrome]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.117

Anti-myelin-associated glycoprotein antibodies and endoneurial cryoglobulin deposits responsible for a severe neuropathy.

31 March 2020

1 reference

12 December 2020

Chronic inflammatory polyradiculoneuropathy

1 reference

12 December 2020

Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

Peripheral neuropathy and anti-MAG antibodies

1 reference

12 December 2020

Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases

1 reference

12 December 2020

[Pathology of Crow-Fukase syndrome]

1 reference

12 December 2020

Segmental demyelination secondary to axonal degeneration in uremic neuropathy

1 reference

12 December 2020

Neuropathy with onion bulb formations and pure motor manifestations

1 reference

12 December 2020

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first

1 reference

12 December 2020

10.1038/NRNEUROL.2014.117

Identifiers

DOI

1 reference

PubMed ID

24980070

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

24980070